GGrantIndex
← Leaderboards

John O Trent

University Of Louisville

$4,178,948
Attributed
$5,534,298
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $504.5K · FY200520
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$5,534,298 · 10

By mechanism

R01$3,967,601 · 2
P20$789,038 · 7
P30$777,659 · 1

Top collaborators

Most similar at University Of Louisville

Same institution · by research overlap

Others in their field

Top investigators on “Virtual

Research focus

VirtualPharmaceutical PreparationsFundingBaseProgramsBiologicalStructureMolecular TargetUnited States National Institutes Of HealthResearch PersonnelGrantDesignDrug DesignStructural BiologyCore FacilityComputer SimulationNovel TherapeuticsMolecular ModelingValidationCancer CenterCenters Of Research ExcellenceG-QuartetsResourcesProperty

Grant awards (26)

Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$355,395
R01 · FY2020 · GM
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$355,395
R01 · FY2019 · GM
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$355,395
R01 · FY2018 · GM
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$355,395
R01 · FY2017 · GM
Molecular Modelling Core$149,132
P30 · FY2017 · GM · contact PI
Molecular Modelling Core$157,132
P30 · FY2016 · GM · contact PI
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$325,203
R01 · FY2015 · GM
Molecular Modelling Core$157,132
P30 · FY2015 · GM · contact PI
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$325,242
R01 · FY2014 · GM
Molecular Modelling Core$157,132
P30 · FY2014 · GM · contact PI
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$313,896
R01 · FY2013 · GM
Molecular Modelling Core$157,131
P30 · FY2013 · GM · contact PI
Targeting Nucleic Acids with an Integrated Virtual and Actual Screen$324,780
R01 · FY2012 · GM
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$116,394
P20 · FY2011 · RR · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$117,569
P20 · FY2010 · RR · contact PI
Development of Nucleolin targeted Anticancer Compounds$247,752
R01 · FY2009 · CA · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$57,036
P20 · FY2009 · RR · contact PI
Development of Nucleolin targeted Anticancer Compounds$247,658
R01 · FY2008 · CA · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$102,502
P20 · FY2008 · RR · contact PI
Development of Nucleolin targeted Anticancer Compounds$247,658
R01 · FY2007 · CA · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$107,859
P20 · FY2007 · RR · contact PI
Development of Nucleolin targeted Anticancer Compounds$255,055
R01 · FY2006 · CA · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$110,670
P20 · FY2006 · RR · contact PI
Development of Nucleolin targeted Anticancer Compounds$258,777
R01 · FY2005 · CA
COBRE: LOUISVILLE RES FOUND INC: CORE C: MOLECULAR MODELING FACILITY$81,796
P20 · FY2005 · RR
CORE-- MOLECULAR MODELING FACILITY$95,212
P20 · FY2004 · RR